Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”

Saved in:
Bibliographic Details
Main Authors: Thi Ha Chau Tran, Stéphane Dumas, Florence Coscas
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2018/9171269
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560994667200512
author Thi Ha Chau Tran
Stéphane Dumas
Florence Coscas
author_facet Thi Ha Chau Tran
Stéphane Dumas
Florence Coscas
author_sort Thi Ha Chau Tran
collection DOAJ
format Article
id doaj-art-0f24d20db43d430baa9af96425bed01b
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-0f24d20db43d430baa9af96425bed01b2025-02-03T01:26:13ZengWileyJournal of Ophthalmology2090-004X2090-00582018-01-01201810.1155/2018/91712699171269Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”Thi Ha Chau Tran0Stéphane Dumas1Florence Coscas2Ophthalmology Department, Lille Catholic Hospitals, Lille Catholic University, Lille, FranceClinique de la Louvière, Lille, FranceCentre Ophtalmologique de l’Odéon, Université Paris-Est Créteil (UPEC), Paris, Francehttp://dx.doi.org/10.1155/2018/9171269
spellingShingle Thi Ha Chau Tran
Stéphane Dumas
Florence Coscas
Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”
Journal of Ophthalmology
title Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”
title_full Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”
title_fullStr Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”
title_full_unstemmed Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”
title_short Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”
title_sort corrigendum to two year outcome of aflibercept in patients with pigment epithelial detachment due to neovascular age related macular degeneration namd refractory to ranibizumab
url http://dx.doi.org/10.1155/2018/9171269
work_keys_str_mv AT thihachautran corrigendumtotwoyearoutcomeofafliberceptinpatientswithpigmentepithelialdetachmentduetoneovascularagerelatedmaculardegenerationnamdrefractorytoranibizumab
AT stephanedumas corrigendumtotwoyearoutcomeofafliberceptinpatientswithpigmentepithelialdetachmentduetoneovascularagerelatedmaculardegenerationnamdrefractorytoranibizumab
AT florencecoscas corrigendumtotwoyearoutcomeofafliberceptinpatientswithpigmentepithelialdetachmentduetoneovascularagerelatedmaculardegenerationnamdrefractorytoranibizumab